MoonLake Immunotherapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MLTX and other ETFs, options, and stocks.About MLTX
Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases.
MLTX Key Statistics
Stock Snapshot
MoonLake Immunotherapeutics(MLTX) stock is priced at $17.20, giving the company a market capitalization of 1.24B. It carries a P/E multiple of -4.82.
As of 2026-05-06, MoonLake Immunotherapeutics(MLTX) stock has fluctuated between $17.20 and $17.30. The current price stands at $17.20, placing the stock 0.0% above today's low and -0.6% off the high.
MoonLake Immunotherapeutics(MLTX) shares are trading with a volume of 5.69K, against a daily average of 712.14K.
In the last year, MoonLake Immunotherapeutics(MLTX) shares hit a 52-week high of $62.75 and a 52-week low of $5.95.
In the last year, MoonLake Immunotherapeutics(MLTX) shares hit a 52-week high of $62.75 and a 52-week low of $5.95.
Analyst ratings
76%
of 17 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.